Noah Haber
About
In The Last Decade
Noah Haber
19 papers receiving 679 citations
Peers
Comparison fields: 5 of 109
- Infectious Diseases 397
- Epidemiology 228
- General Health Professions 183
- Economics and Econometrics 94
- Virology 71
Countries citing papers authored by Noah Haber
This map shows the geographic impact of Noah Haber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noah Haber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noah Haber more than expected).
Fields of papers citing papers by Noah Haber
This network shows the impact of papers produced by Noah Haber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noah Haber. The network helps show where Noah Haber may publish in the future.
Co-authorship network of co-authors of Noah Haber
This figure shows the co-authorship network connecting the top 25 collaborators of Noah Haber. A scholar is included among the top collaborators of Noah Haber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noah Haber. Noah Haber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 34 | |
| 4 | 136 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 56 | |
| 8 | 15 | |
| 9 | Letter of concern regarding »Reduction in COVID-19 infection using surgical facial masks outside the healthcare system«. | 2 |
| 10 | Policy evaluation in COVID-19: A graphical guide to common design issues | 2 |
| 11 | 62 | |
| 12 | 11 | |
| 13 | 5 | |
| 14 | 2 | |
| 15 | 70 | |
| 16 | 91 | |
| 17 | 61 | |
| 18 | 111 | |
| 19 | Cardiometabolic consequences of therapy for chronic schizophrenia using second-generation antipsychotic agents in a medicaid population: clinical and economic evaluation. | 12 |
| 20 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.